$0.732
-0.046 (-6.25%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Connect Biopharma Holdings Ltd (CNTB) Moving Averages Convergence Divergence (MACD) indicator is -0.12, suggesting CNTB is Strong sell.
Connect Biopharma Holdings Ltd (CNTB) 20-Day simple moving average is 0.83, while Connect Biopharma Holdings Ltd (CNTB) share price is $—, making it Sell.
Connect Biopharma Holdings Ltd (CNTB) 60-Day simple moving average is 1.40, while Connect Biopharma Holdings Ltd (CNTB) share price is $—, making it Sell.
Technical Analysis for CNTB
AI Technical CNTBAs of 2026-11-03, the technical board for Connect Biopharma Holdings Ltd (CNTB) reads strong sell: 2 indicators are flashing buy, 9 are indicating sell, and 2 are neutral. Price at $0.73 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 29.07, MACD stands at -0.115 (Sell), Stochastic %K stands at 15.587 (Buy), Stochastic %D stands at 19.432 and CCI stands at -136.564 (Buy).
CNTB trades below the 60-day SMA (1.40) and below the 200-day SMA (2.15). Immediate resistance sits at Classic R1 0.89, then R2 0.98. Support sits at Classic S1 0.71, then S2 0.62.
Connect Biopharma Holdings Ltd (CNTB) Support & Resistance Level
Connect Biopharma Holdings Ltd (CNTB) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 29.070 |
| STOCHk_14_3_3 | 15.587 |
| STOCHd_14_3_3 | 19.432 |
| CCI_20 | -136.564 |
| AO_5_34 | -0.156 |
| MOM_10 | -0.038 |
| MACD_12_26_9 | -0.115 |
Connect Biopharma Holdings Ltd (CNTB) Relative Strength Index (RSI_14) is 29.070, creating a Buy signal.
Connect Biopharma Holdings Ltd (CNTB) Stochastic %K is 15.587, creating a Buy signal.
Connect Biopharma Holdings Ltd (CNTB) Stochastic %D is 19.432, creating a Buy signal.
Connect Biopharma Holdings Ltd (CNTB) CCI_20 is -136.564, creating a Buy signal.
Connect Biopharma Holdings Ltd (CNTB) Awesome Oscillator (AO) is -0.156, creating a Sell signal.
Connect Biopharma Holdings Ltd (CNTB) Momentum (MOM) is -0.038, creating a Sell signal.
Connect Biopharma Holdings Ltd (CNTB) Moving Average Convergence Divergence (MACD) is -0.115, creating a Sell signal.
Connect Biopharma Holdings Ltd (CNTB) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 0.758 | Sell |
| MA_10 | 0.797 | Sell |
| MA_20 | 0.831 | Sell |
| MA_60 | 1.399 | Sell |
| MA_200 | 2.154 | Sell |
| MA_250 | 2.210 | Sell |
Connect Biopharma Holdings Ltd (CNTB) 5-Day simple moving average is 0.758, while Connect Biopharma Holdings Ltd (CNTB) share price is $, making it a Sell.
Connect Biopharma Holdings Ltd (CNTB) 10-Day simple moving average is 0.797, while Connect Biopharma Holdings Ltd (CNTB) share price is $, making it a Sell.
Connect Biopharma Holdings Ltd (CNTB) 20-Day simple moving average is 0.831, while Connect Biopharma Holdings Ltd (CNTB) share price is $, making it a Sell.
Connect Biopharma Holdings Ltd (CNTB) 60-Day simple moving average is 1.399, while Connect Biopharma Holdings Ltd (CNTB) share price is $, making it a Sell.
Connect Biopharma Holdings Ltd (CNTB) 200-Day simple moving average is 2.154, while Connect Biopharma Holdings Ltd (CNTB) share price is $, making it a Sell.
Connect Biopharma Holdings Ltd (CNTB) 250-Day simple moving average is 2.210, while Connect Biopharma Holdings Ltd (CNTB) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.